Co-expression of recombinant proteins

a recombinant protein and co-expression technology, applied in the field of molecular biology, biochemistry and vaccinology, can solve the problems of increased production time and cost, and increased production cost, and achieves stable proteolytic activity

Inactive Publication Date: 2007-02-08
LOOSMORE SHEENA M +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This approach results in high-yield production of stable, soluble recombinant proteins, including H91A Hin47, V38 rHia, and PsaA, which can be effectively purified and used as vaccine candidates, reducing production time and costs by enabling simultaneous production and separation of multiple antigens.

Problems solved by technology

While the purification of inclusion bodies is relatively straightforward and can lead to a >90% purification of the recombinant protein, the resulting protein is often denatured and may be biologically inactive.
Co-expression of recombinant proteins encoded on genes from multiple organisms can lead to improved production time and costs.
The HtrA proteins are serine proteases and their proteolytic activity makes them unstable.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Co-expression of recombinant proteins
  • Co-expression of recombinant proteins
  • Co-expression of recombinant proteins

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0063] This Example describes the construction of plasmid JB-3120-2, which contains the T7 H91A hin47 gene encoding the endogenous leader sequence. The procedure employed is shown schematically in FIG. 1A.

[0064] The production of the mature recombinant H91A Hin47 protein from E. coli has been described in the aforementioned U.S. Pat. No. 5,506,139. This protein was produced at 40 to 50% of total protein in a soluble form. The bacterial HtrA proteins are located in the periplasmic membrane and may function as chaperones if located there. In order to direct the mutant, non-proteolytic H91A Hin47 protein to the periplasmic membrane, the endogenous leader was added. Plasmid DS-2140-3 is a pBR328-based plasmid that contains the T7 H91A hin47 gene cassette between EcoR I and Cla I sites (FIG. 1A). Plasmid JB-1 172-2-5 is a pUC-based plasmid that contains the wild-type htrA gene with 5′- and 3′-flanking sequences. Plasmid JB-1172-2-5 was digested with Cla I and Sal I and the 0.6 kb 3′-fla...

example 2

[0065] This Example describes the production and purification of recombinant H91A Hin47 protein with its endogenous leader sequence.

[0066] Cells were grown at 37° C. in NZCYM medium using the appropriate antibiotic selection to A578 of 0.3 before addition of lactose to 1.0% for 4 hours. Samples were adjusted to 0.2 OD / μl with SDS-PAGE lysis+loading buffer and the same amount of each protein sample was loaded onto SDS-PAGE gels (ref 18). The mature H91A Hin47 protein was produced at ˜50% of total protein, while the H91A Hin47+leader protein was produced at 20 to 25% of total protein (FIG. 2).

[0067] The purification of the mature soluble H91A Hin47 protein has been described in U.S. Pat. No. 5,506,139. The H91A Hin47 +leader protein was found to be associated with the pellet after two extractions of E. coli cells with 50 mM Tris-HCl, pH 8.0 and 50 mM Tris-HCl, pH 8.0 containing 0.5% Triton X-100 and 10 mM EDTA. The pellet containing H91A Hin47 was solubilized in 50 mM Tris-HCl, pH 8...

example 3

[0069] This Example illustrates the construction of plasmid DS-2342-2-2, which contains the T7 H91A hin47, T7 V38 hia, and E. coli cer genes. The procedure employed is shown schematically in FIG. 5.

[0070] Plasmid DS-1872-2-2 is a pBR328-based vector containing a 2.2 kb EcoR I T7 H91A hin47 gene cassette (FIG. 5). Plasmid BK-96-2-11 is a pBR328-based vector that contains a T7 V38 hia gene cassette, the E. coli cer gene, and a kanamycin resistance gene; and this plasmid has been described in the aforementioned U.S. patent application Ser. No. 09 / 268,347. BK-96-2-11 was linearized by digestion with EcoR I, dephosphorylated, and the EcoR I T7 H91A hin47 gene fragment inserted, to generate plasmid DS-2342-2-2, that co-expresses the H91A hin47 and V38 hia genes. This plasmid thus contains tandem T7 H91A hin47 and T7 V38 hia genes in the same orientation. Plasmid DNA was introduced into electrocompetent E. coli BL21(DE3) cells using a BioRad electroporator, and recombinant E. coli strain ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
ODaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

Expression vectors are described which permit the recombinant expression of proteins which essentially contain, in addition to nucleic acid encoding the recombinant protein, nucleic acid encoding a non-proteolytic analog of Haemophilus Hin47 protein, with or without leader sequence, or nucleic acid encoding high molecular weight proteins of non-typeable Haemophilus, which are hmwB, hmwC or hmwBC.

Description

FIELD OF THE INVENTION [0001] The present invention relates to the fields of molecular biology, biochemistry and vaccinology, in particular, to the co-expression of recombinant proteins. BACKGROUND TO THE INVENTION [0002] Recombinant proteins expressed from E. Coli, are often made as insoluble inclusion bodies. While the purification of inclusion bodies is relatively straightforward and can lead to a >90% purification of the recombinant protein, the resulting protein is often denatured and may be biologically inactive. In some instances, it may be advantageous to overproduce a recombinant protein in a soluble form. Recombinant proteins can also be degraded by host proteases. Expression of recombinant proteins in the presence of particular proteins, such as potential molecular chaperones, may have the effect of protecting them from degradation and ensure correct folding. In other instances, it may be useful to produce two vaccine components, from different organisms, in the same p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C07K14/285C07H21/04C12N1/21C12N15/74C12N15/63C12N15/70
CPCC07K14/285C12N15/70C12N15/63C07K2319/00
InventorLOOSMORE, SHEENA M.YANG, YAN-PING
OwnerLOOSMORE SHEENA M